TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS - Patent 0563198

(19)

(11)

EP 0 563 198 A1

(12)

(43)	Date of publication:
	06.10.1993 Bulletin 1993/40

(21)	Application number: 92901859.0

(22)	Date of filing: 23.12.1991

(51)

International Patent Classification (IPC):

A61K 39/ 395^{( . )}
A61P 35/ 00^{( . )}
C07K 16/ 00^{( . )}
C07K 19/ 00^{( . )}
C12P 21/ 02^{( . )}

A61K 47/ 48^{( . )}
C07K 14/ 435^{( . )}
C07K 16/ 46^{( . )}
C12N 15/ 09^{( . )}
C12R 1/ 19^{( . )}

(86)	International application number:
	PCT/GB1991/002303

(87)	International publication number:
	WO 1992/011031 (09.07.1992 Gazette 1992/17)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

(30)

Priority:

21.12.1990 GB 19900027767

(71)	Applicant: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
	Melbourn, Cambridgeshire SG8 6EJ (GB)

(72)	Inventors:
	JOHNSON, Kevin, Stuart 32 Holmehill Cambridgeshire PE18 8EX (GB) CHISWELL, David, John 1 Sandhill House Buckingham MK18 2LD (GB)

(74)	Representative: Armitage, Ian Michael
	MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP London WC2B 6HP (GB)

(54)	TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS